Now I have read the full paper. Let me evaluate the rebuttal claims against the actual paper content.

---

## Summary

This paper is a scientific comment that systematically refutes, claim by claim, statements made by Palazzo et al. (2024) in a TPAMI response to a prior comment (Bharadwaj et al., 2023). The underlying dispute is whether EEG classification results from block-design datasets (Spampinato et al. 2017 and related work) are inflated by a temporal confound. The paper presents six factual rebuttals using direct citation, plus new empirical work (frequency-domain supertrial analysis, Table 1) and novel analytical distinctions in Section 8.

---

## Rebuttal Assessment

**Weakness: Venue mismatch / minimal new contribution**
- **Author's response:** Partially address — Authors enumerate three distinct new contributions: (1) frequency-domain supertrial Table 1, (2) within-run vs. between-run temporal correlation distinction in Section 8, (3) leave-one-subject-out argument in Section 8.
- **Assessment:** Partially convincing. All three claimed contributions are verified in the paper. (1) The frequency-domain supertrial analysis is confirmed novel — the paper at lines 136–143 quotes Bharadwaj et al. (2023) proposing this only as a "future direction," and Table 1 presents original results. (2) The within-run vs. between-run distinction at lines 248–250 is genuinely present: *"the former has considerably higher accuracy than the latter, yet both are considerably above chance"* — this explains why the BDB analysis is not exculpatory and does appear to be novel framing not present in prior publications. (3) The LOSO argument at lines 276–280 is also in the paper. However, the original review's characterization of the paper as "fundamentally reactive" is still accurate — all three contributions exist to rebut specific Palazzo et al. (2024) claims rather than advance a new direction. The within-run/between-run distinction is arguably the most substantive new analytical insight, though it is an interpretation of Li et al. (2021)'s existing tables rather than new data.
- **Score impact:** Weakness downgraded (from Major to moderate Major — the paper has more substance than originally credited, but venue fit remains a real concern)

**Weakness: Figure 1 spectral claim is visually ambiguous**
- **Author's response:** Partially address — Authors acknowledge the ambiguity and pivot to Table 1 as the primary evidence, with the historical precedence argument as a secondary pillar.
- **Assessment:** Convincing pivot. The figure caption (lines 168–172) confirms the reviewer's concern: "All spectra show a general downward trend as frequency increases, with the raw trials having the highest power and the 100 supertrial size having the lowest power." The text at lines 151–152 claims this "amplifies" higher-frequency components, but amplification is relative to time-domain averaging, which is absent from the figure. The amplification claim as stated in the paper is indeed undersubstantiated. However, the authors correctly identify that the decisive evidence is Table 1: EEGChannelNet is at chance for all N=1 through N=100 under frequency-domain supertrials (verified in paper lines 176–188), while other classifiers (SVM, 1D CNN, EEGNet, SyncNet) achieve statistical significance. The historical precedence argument (lines 162–190) also requires no figure. The weakness does not undermine the core conclusion.
- **Score impact:** Weakness unchanged in nature but correctly contextualized as Minor (primary conclusion stands)

**Weakness: No early framing for the ICLR audience**
- **Author's response:** Partially address — Authors acknowledge the Introduction lacks community framing and state this is a presentation improvement they can make. The community argument is in the Ethics Statement.
- **Assessment:** Unconvincing as a rebuttal. The authors acknowledge the weakness exists in the current paper and offer only a "we will fix this" response. Verified in paper: Section 1 (lines 15–16) does not mention the ~100 affected papers or ML conference relevance. The Ethics Statement (lines 299–366) provides this, but a conference reader reads Introduction first. A promised revision does not address the current paper's state.
- **Score impact:** Weakness unchanged

---

## Strengths
- **Precise factual rebuttals grounded in primary sources.** Each of the six contested claims is refuted with direct quotation from Bharadwaj et al. (2023), Ahmed et al. (2021), or Spampinato et al. (2017). E.g., session length is verifiably 350 s from Table 1 of Spampinato et al., not "about 4 minutes" (lines 61–62); seven subjects total are reported in Bharadwaj et al. (2023) (lines 104–107).
- **Table 1 directly falsifies the core spectral claim.** EEGChannelNet remains at chance across all N=1–100 under frequency-domain supertrials; EEGNet achieves significance at N=1–10 and N=100 (5.3%*). This is decisive evidence that EEGChannelNet's failure is not due to high-frequency attenuation by the supertrial method.
- **Novel within-run vs. between-run temporal correlation distinction (Section 8).** The paper correctly shows that the BDB analysis of Palazzo et al. measures between-block cross-run correlation (Li et al. 2021, Table 15) rather than within-block within-run correlation (Table 6), and that the former is weaker — explaining why the BDB results are not exculpatory. This distinction is substantive and verifiably present in the paper.
- **Compelling Ethics Statement.** The ~100 affected papers (listed by name, lines 337–357) with enumerated harms (grant awards, degrees, BCI medical implications) makes a concrete case for community relevance.

---

## Weaknesses

### Fatal
None.

### Major
- **Venue mismatch with limited forward-looking contribution.** The paper is reactive by design: every section exists only because Palazzo et al. (2024) made specific claims. The three new contributions identified in the rebuttal (frequency-domain supertrials, within/between-run distinction, LOSO rebuttal) are all genuine but all exist to rebut, not advance. No new dataset, benchmark, method, or evaluation framework is produced. The within-run/between-run distinction interprets existing Li et al. (2021) tables. This concern is real and unresolved by the rebuttal, though the paper's substance is somewhat greater than initially credited.

### Minor
- **Figure 1 does not support the spectral "amplification" claim.** The figure caption confirms that all spectra decrease with frequency and raw trials have highest power — visually opposite to "amplification." The amplification claim (relative to time-domain averaging) is stated in the text but requires a comparison figure that does not exist. The primary result (Table 1) is unaffected.
- **No early framing for the ICLR audience.** Section 1 presents no community-relevance argument; this appears only in the Ethics Statement. Authors acknowledge this but offer only a future-revision commitment, which does not count.

### Trivial
None.

---

## Nice-to-Haves
- Overlay time-domain and frequency-domain supertrial spectra at matched N on the same axes to make the "amplification" claim visually verifiable.
- Move one sentence from the Ethics Statement ("nearly one hundred ML conference papers are affected") into the Introduction's second paragraph.
- Add an "effect size" sentence near the top of Section 8 citing the accuracy drop when the temporal confound is removed (from Li et al. 2021), so readers unfamiliar with prior literature can quantify what is at stake.

---

## Novel Insights

The sharpest analytical contribution — partially overlooked in the original review — is the within-run vs. between-run temporal correlation distinction in Section 8. The paper demonstrates that Li et al. (2021) documented *two* types of temporal confound: within-block within-run (Table 6, very high accuracy above chance) and between-block cross-run (Table 15, weaker but still above chance). The BDB analysis of Palazzo et al. (2020b) measures only the latter and therefore systematically underestimates the strength of the confound that actually produced Spampinato et al.'s inflated results. This is a specific, verifiable, and substantive point that explains the logical gap in Palazzo et al.'s exculpatory argument — not just "you can't prove a negative" (Frost 2024) but "you measured the wrong thing." Combined with the LOSO argument (leave-one-subject-out accuracy drop despite multi-subject training pooling), this Section 8 analysis is the most original intellectual content in the paper.

---

## Suggestions
1. Add a direct comparison figure: overlay time-domain and frequency-domain supertrial spectra at matched N values to make the amplification claim directly visually verifiable.
2. Restructure the Introduction to include a two-sentence orienting paragraph pointing to the ~100 affected ML conference papers, so the paper's relevance is immediately clear.
3. Explicitly cite the accuracy drop magnitude from Li et al. (2021) in Section 8's opening, so readers can quantify the stake without reading backwards through the paper.

---

## Score and Decision

The rebuttal has meaningfully adjusted the picture compared to the original review. The original review characterized the paper's sole new contribution as "one re-run of the Bharadwaj et al. (2023) analysis with a different averaging method." The rebuttal correctly shows this is inaccurate: the within-run vs. between-run distinction in Section 8 is a genuinely new analytical contribution that is present in the paper and substantive. The frequency-domain supertrial experiment is also verified as new. The Figure 1 weakness is honestly acknowledged and correctly contextualized as secondary to Table 1. These factors justify a slight upward revision.

However, the major concern — venue mismatch with limited forward-looking contribution — is unresolved. The paper remains fundamentally reactive. The three new contributions all exist to rebut rather than advance. No new dataset, benchmark, method, or evaluation framework is produced. The Introduction still lacks community framing (verified in paper). The "we will add this in the revision" responses for the framing and figure issues do not count.

The rebuttal is partially convincing: it correctly identifies genuine contributions that the original review undervalued, but does not substantially change the paper's fundamental character. The score is adjusted marginally upward to reflect the additional substantive content in Section 8.

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>